|
|
G Missale, R Bertoni, V Lamonaca, A Valli, M Massari, C Mori, M G Rumi, M Houghton, F Fiaccadori, C Ferrari
J Clin Invest. 1996;
98(3):706
doi:10.1172/JCI118842
Abstract |
Full text
| PDF

T
he anti-viral T cell response is believed to play a central role in the pathogenesis of hepatitis C virus infection. Since chronic evolution occurs in > 50% of HCV infections, the sequential analysis of the T cell response from the early clinical stages of disease may contribute to define the features of the T cell response associated with recovery or chronic viral persistence. For this purpose, 21 subjects with acute hepatitis C virus infection were sequentially followed for an average time of 44 wk. Twelve patients normalized transaminase values that remained normal throughout the follow-up period; all but two cleared hepatitis C virus-RNA from serum. The remaining nine patients showed persistent viremia and elevated transaminases. Analysis of the peripheral blood T cell proliferative response to core, E1, E2, NS3, NS4, and NS5 recombinant antigens and synthetic peptides showed that responses to all hepatitis C virus antigens, except E1, were significantly more vigorous and more frequently detectable in patients who normalized transaminase levels than in those who did not. By sequential evaluation of the T cell response, a difference between the two groups of patients was already detectable at the very early stages of acute infection and then maintained throughout the follow-up period. The results suggest that the vigor of the T cell response during the early stages of infection may be a critical determinant of disease resolution and control of infection.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(236)
| Title and authors |
Publication |
Year |
Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence
J. Schulze zur Wiesch, D. Ciuffreda, L. Lewis-Ximenez, V. Kasprowicz, B. E. Nolan, H. Streeck, J. Aneja, L. L. Reyor, T. M. Allen, A. W. Lohse
|
Journal of Experimental Medicine
|
2012 |
Failure of innate and adaptive immune responses in controlling hepatitis C virus infection
Robert Thimme, Marco Binder, Ralf Bartenschlager
|
FEMS Microbiology Reviews
|
2012 |
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
E. Barnes, A. Folgori, S. Capone, L. Swadling, S. Aston, A. Kurioka, J. Meyer, R. Huddart, K. Smith, R. Townsend
|
Science Translational Medicine
|
2012 |
Immune Pathogenesis of Viral Hepatitis B and C
Kyong-Mi Chang
|
Zakim and Boyer s Hepatology
|
2012 |
The interferon family as biomarkers of disease: renaissance of the innate immune system
Michaela Lucas, Silvana Gaudieri
|
Biomarkers Med.
|
2012 |
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
Joseph Torresi, Doug Johnson, Heiner Wedemeyer
|
Journal of Hepatology
|
2011 |
Host genetics in immune-mediated hepatitis C virus clearance
Julia Schmidt, Robert Thimme, Christoph Neumann-Haefelin
|
Biomarkers Med.
|
2011 |
Spontaneous clearance of hepatitis C virus in vertically infected children
Susan Farmand, Stefan Wirth, Helga Löffler, Tanja Woltering, Sybille Kenzel, Elke Lainka, Philipp Henneke
|
Eur J Pediatr
|
2011 |
Impact of HCV genetic differences on pathobiology of disease
Maria Ripoli, Valerio Pazienza
|
Expert Rev Anti Infect Ther
|
2011 |
Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users
J. K. Flynn, G. J. Dore, M. Hellard, B. Yeung, W. D. Rawlinson, P. A. White, J. M. Kaldor, A. R. Lloyd, R. A. Ffrench
|
Journal of Viral Hepatitis
|
2011 |
|